Two years after a stage 4 lung cancer diagnosis, Alfonzo Grafton sits down in his home with his Duke oncologist, Dr. Eziafa Oduah, to reflect on the clinical trial that changed his life. Alfonzo was the first patient to receive an experimental medication targeting the PCSK9 protein—part of an NIH-funded study at the Duke Cancer Institute. Alfonzo shares how the trial gave him his life back, from dancing to cheering on Duke basketball in his beloved “Duke Room" to spending time with family and friends. Learn More Did you know your taxpayer dollars fund research that improves cancer survival rates, detects and prevents childhood diseases and relieves pain? Research isn’t just science; it’s about people — your family, friends and community. today.duke.edu/research CHAPTERS 00:00 Intro 00:40 Dr. Eziafa Oduah introduction 01:16 Alfonzo Grafton’s Durham and Duke history 02:39 Diagnosis 04:04 Lung cancer clinical trial 05:13 Trial medication vs Chemo 07:25 Importance of research 0...